Riggs Asset Managment Co. Inc. - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 90 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$12,508
-16.3%
10,6000.0%0.00%
-20.0%
Q2 2023$14,946
-6.0%
10,6000.0%0.01%
-16.7%
Q1 2023$15,900
+28.2%
10,6000.0%0.01%
+20.0%
Q4 2022$12,402
+3.4%
10,6000.0%0.01%0.0%
Q3 2022$12,000
-29.4%
10,6000.0%0.01%
-28.6%
Q2 2022$17,000
+6.2%
10,6000.0%0.01%
+40.0%
Q1 2022$16,000
-38.5%
10,6000.0%0.01%
-28.6%
Q4 2021$26,000
-3.7%
10,6000.0%0.01%
-12.5%
Q3 2021$27,000
-10.0%
10,6000.0%0.01%0.0%
Q2 2021$30,000
+20.0%
10,6000.0%0.01%0.0%
Q1 2021$25,000
+31.6%
10,6000.0%0.01%
+33.3%
Q4 2020$19,000
+90.0%
10,600
-8.6%
0.01%
+50.0%
Q2 2020$10,000
+11.1%
11,6000.0%0.00%
-33.3%
Q1 2020$9,000
-10.0%
11,6000.0%0.01%
+50.0%
Q4 2019$10,000
-9.1%
11,6000.0%0.00%
-33.3%
Q3 2019$11,00011,6000.01%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 4,735,990$8,335,0003.63%
BROADWOOD CAPITAL INC 34,005,379$59,849,0003.55%
Prescott General Partners LLC 1,851,851$3,259,0000.14%
Strategic Wealth Investment Group, LLC 66,917$118,0000.07%
Laidlaw Wealth Management LLC 170,658$300,0000.06%
Humankind Investments LLC 26,737$47,0000.05%
DAFNA Capital Management LLC 80,000$141,0000.04%
Beirne Wealth Consulting Services, LLC 45,000$79,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 680,839$1,198,0000.02%
Allegheny Financial Group LTD 20,000$35,0000.02%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders